The outcome prompteed an independent data monitoring committee recommended patients who are on placebo should be offered Zytiga, which was approved to treat advancedprostatecancer patients who did not benefit from chemo.
Often the symptoms of prostatecancer only start to show once the disease is fairly advanced but men should be alert if they start needing to urinate frequently or if they have difficulty in urinating.